T-0156

T-0156

0T-0156 is a chemical compound that belongs to the class of pharmacological agents known as PDE5 inhibitors. It is primarily used in the research of erectile dysfunction and pulmonary arterial hypertension.

Chemistry

T-0156 is a synthetic compound that is structurally similar to other PDE5 inhibitors such as sildenafil and vardenafil. It is characterized by its unique benzimidazole ring structure, which differentiates it from other compounds in its class.

Pharmacology

As a PDE5 inhibitor, T-0156 works by blocking the action of the enzyme phosphodiesterase type 5 (PDE5). This enzyme is responsible for the breakdown of cyclic guanosine monophosphate (cGMP), a substance that promotes relaxation and dilation of the blood vessels. By inhibiting PDE5, T-0156 allows cGMP to accumulate, leading to enhanced blood flow and improved erectile function.

Clinical Use

While T-0156 is not currently approved for clinical use, it has been extensively studied in preclinical trials for its potential applications in treating erectile dysfunction and pulmonary arterial hypertension. Its efficacy and safety profile are still under investigation.

Research

Research on T-0156 has primarily focused on its potential use in treating erectile dysfunction and pulmonary arterial hypertension. Studies have shown that it has a potent and selective inhibitory effect on PDE5, making it a promising candidate for further research in these areas.

See Also

• Phosphodiesterase type 5
• Erectile dysfunction
• Pulmonary arterial hypertension

This article is a stub related to chemistry. You can help WikiMD by expanding it!

This article is a stub related to pharmacology. You can help WikiMD by expanding it!